ReviewFrontiers in cell and developmental biology2026

Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy.

Dongmei Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.